Tadamasa Shibuya
Overview
Explore the profile of Tadamasa Shibuya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shibuya T, Inoue T, Ando T, Shin T
IJU Case Rep
. 2024 Nov;
7(6):476-479.
PMID: 39498188
Introduction: We report a case of troubleshooting against bleeding from an inferior vena cava injury using a gelatin-thrombin matrix. Case Presentation: A 58-year-old man underwent robot-assisted partial adrenalectomy for a...
2.
Shinohara M, Hata S, Inoue T, Shibuya T, Ando T, Mimata H, et al.
Mol Clin Oncol
. 2024 Apr;
20(5):37.
PMID: 38628558
Gemcitabine plus cisplatin (GC) is the standard first line of chemotherapy for urothelial carcinoma. However, it is often difficult to complete scheduled GC therapy because of real-world adverse events. Therefore,...
3.
Abe S, Inoue T, Hata S, Shibuya T, Ando T, Shin T
Urol Case Rep
. 2024 Mar;
53:102662.
PMID: 38444618
Collecting duct carcinoma, also known as Bellini duct cancer, is a rare subtype of renal cell carcinoma with a poor prognosis in the metastatic setting. There are limited data to...
4.
Impact of Fish Intake Frequency on Cardiovascular Disease-Specific Survival in Hemodialysis Patients
Ando T, Murakami T, Fujiyama S, Sejiyama S, Murakami K, Miki D, et al.
JMA J
. 2024 Feb;
7(1):85-93.
PMID: 38314428
Introduction: Cardiovascular disease (CVD) is the leading cause of death in hemodialysis patients (HPs). As a food source, fish contains both CVD-preventive and CVD-promoting fatty acids; however, there is no...
5.
Nishiyama N, Kita Y, Ito K, Kato M, Hatakeyama S, Matsushita Y, et al.
Anticancer Res
. 2023 Nov;
43(11):5041-5050.
PMID: 37909969
Background/aim: To evaluate the difference in the clinical efficacy and safety of pembrolizumab between patients with metastatic upper tract urothelial carcinoma (UTUC), which includes renal pelvic urothelial carcinoma (UC) and...
6.
Ando T, Nakashima S, Abe S, Watanabe D, Iwasaki K, Shinohara M, et al.
IJU Case Rep
. 2022 Jul;
5(4):297-299.
PMID: 35795123
Introduction: Mamushi bites are the most common venomous snakebites in Japan. The clinical course of a common mamushi bite is known, and its alarming complication and cause of death are...
7.
Mukai S, Sakamoto N, Kakinoki H, Shibuya T, Moriya R, Nishihara K, et al.
J Clin Med
. 2022 Jun;
11(12).
PMID: 35743608
Objectives: To evaluate the management and outcome of idiopathic retroperitoneal fibrosis (iRPF) in Japan, and to identify its clinical biomarker. Methods: We retrospectively analyzed 129 patients with iRPF treated between...
8.
Miyamoto S, Yoshida Y, Ozeki Y, Okamoto M, Gotoh K, Masaki T, et al.
J Endocr Soc
. 2021 Dec;
5(12):bvab163.
PMID: 34870059
Predominantly or exclusively dopamine-secreting pheochromocytoma and paraganglioma are very rare. We report a 64-year-old woman with an adrenal incidentaloma. She was normotensive and had no symptoms of catecholamine excess. The...
9.
Taoka R, Kobayashi T, Hidaka Y, Abe H, Ito K, Kojima T, et al.
Urol Oncol
. 2021 Aug;
40(3):107.e1-107.e9.
PMID: 34454824
Objective: The aim of this study was to determine whether a history of treatment for non-muscle invasive bladder cancer (NMIBC), including intravesical bacillus Calmette-Guerin (BCG) therapy, affects the treatment outcomes...
10.
Kobayashi M, Narita S, Matsui Y, Kanda S, Hidaka Y, Abe H, et al.
BJU Int
. 2021 Jun;
130(2):226-234.
PMID: 34110696
Objectives: To assess the impact of histological variants on survival and response to treatment with pembrolizumab in patients with chemo-resistant urothelial carcinoma (UC). Patients And Methods: The medical records of...